JNJ
Johnson & Johnson
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Market Cap: 384 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: https://www.jnj.com/
Shares Outstanding: 2.41 Billion
Float: 0
Dividend: 4.705887702299901 (0.03%)
Beta: 0.2551518766511751
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 716 trading days
From: 2018-01-22 To: 2020-01-15
Lowest Point:
Oil Bounces On Tanker 'Incident' (Wall Street Breakfast Podcast)
via: SeekingAlpha at 2019-06-13 03:41:02:000
Today's Top Stories: Protests roil Hong Kong markets; winning streak snapped; and adapting to tariffs. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher… read more...
Wall Street Breakfast: Oil Spikes After Tanker Attacks
via: SeekingAlpha at 2019-06-13 03:01:43:000
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). For the last few sessions , crude prices have been flashing red as they neared the $50 level, but att… read more...
Bunker Dividend Growth Portfolio: Our 17th Dividend Aristocrat
via: SeekingAlpha at 2019-06-13 01:30:25:000
(Source: imgflip ) Note that to avoid reader confusion, I've shifted to a rotating portfolio update schedule. I'll now be providing just one update per week, alternating between my retirement portfolio (where I keep 100% of my life savings), and this model portfolio made up entirely of … read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
The Crazy Stuff That Happens To A Stock Portfolio
via: SeekingAlpha at 2019-06-12 01:09:46:000
It seems that every few months I get a portfolio shocker. There's often big news surrounding the individual stocks. I'll admit that I do not watch my holdings all that closely, but I certainly get all of the news feeds of my portfolio holdings courtesy of my Seeking Alpha home page. Yesterda… read more...
J&J's Invokana shows CV benefit in type 2 diabetics with kidney disease
via: SeekingAlpha at 2019-06-11 09:06:25:000
Results from a Phase 3 clinical trial, CREDENCE , evaluating Johnson & Johnson ( JNJ +0.7% ) unit Janssen Pharmaceuticals' INVOKANA (canagliflozin) in patients with type 2 diabetes (T2D) and chronic kidney disease showed a positive effect cardiovascular (CV)risk. The data wer… read more...
Genmab inks deal with J&J for next-gen anti-CD38 antibody
via: SeekingAlpha at 2019-06-11 03:51:01:000
Building on their successful partnership developing Darzalex (daratumumab), Genmab A/S ( GMAB ) inks an agreement with Johnson & Johnson (NYSE: JNJ ) unit Janssen Biotech granting the latter an option for an exclusive global license to develop and commercialize a next-generation huma… read more...
Zymeworks: Leader In Bispecifics Space Makes Substantial Headway
via: SeekingAlpha at 2019-06-11 02:07:59:000
Shares of Zymeworks ( ZYME ) have nearly doubled since I suggested that readers "buy the dip" in February 2018. In that article, I pointed out that a bet on the stock was not merely a wager on prospects for lead program ZW25, but also on its impressive platform technologies with several part… read more...
FDA Ad Com tomorrow on utility of higher-dose opioids
via: SeekingAlpha at 2019-06-10 13:06:51:000
The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee will jointly mee t tomorrow and Wednesday, June 11 & 12, to seek public input on the clinical utility and safety concerns associated with higher range opioid an… read more...
Our Family Investments: May Purchases
via: SeekingAlpha at 2019-06-10 03:51:01:000
After a very busy couple years, our family finds itself in a position to continue building our investment portfolios. Back in December, I highlighted a couple purchases we made in my end-of-the-year review . Going forward, we plan on adding to a couple positions a month through five different… read more...
How To Retire At 62 With $1.25 Million
via: SeekingAlpha at 2019-06-10 03:20:56:000
This research report was produced with assistance from Big Dog Investments . Well, lads, its time for this couple to retire. When youre ready for retirement, you need to be able to balance yield with safety. Too many investors focus on only one aspect. One way to i… read more...
Dividend Champion And Contender Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:31:28:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
Buy Merck For Growth And Its Good Pipeline Of Breakthrough Drugs
via: SeekingAlpha at 2019-06-09 16:11:39:000
Merck ( MRK ) is a buy for the total return investor that also wants some income as the world economy grows. Merck is one of the largest drug companies in the world. MRK is a conservative investment since it is also a defensive company if the market turns down. Merck will be reviewed using T… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-08-26 | 2019-09-10 | 2019-08-27 | 2019-07-15 | 0.95 | No Change QoQ | |||
| 2019-05-24 | 2019-06-11 | 2019-05-28 | 2019-04-25 | 0.95 | Increase | |||
| 2019-02-25 | 2019-03-12 | 2019-02-26 | 2019-01-02 | 0.9 | No Change QoQ | |||
| 2018-11-26 | 2018-12-11 | 2018-11-27 | 2018-10-18 | 0.9 | No Change QoQ | |||
| 2018-08-27 | 2018-09-11 | 2018-08-28 | 2018-07-16 | 0.9 | No Change QoQ | |||
| 2018-05-25 | 2018-06-12 | 2018-05-29 | 2018-04-26 | 0.9 | Increase | |||
| 2018-02-26 | 2018-03-13 | 2018-02-27 | 2018-01-02 | 0.84 | No Change QoQ | |||
| 2017-11-27 | 2017-12-12 | 2017-11-28 | 2017-10-19 | 0.84 | No Change QoQ | |||
| 2017-08-25 | 2017-09-12 | 2017-08-29 | 2017-07-17 | 0.84 | No Change QoQ | |||
| 2017-05-25 | 2017-06-13 | 2017-05-30 | 2017-04-27 | 0.84 | Increase | |||
| 2017-02-24 | 2017-03-14 | 2017-02-28 | 2017-01-03 | 0.8 | No Change QoQ | |||
| 2016-11-18 | 2016-12-06 | 2016-11-22 | 2016-10-20 | 0.8 | No Change QoQ | |||
| 2016-08-19 | 2016-09-06 | 2016-08-23 | 2016-07-18 | 0.8 | No Change QoQ | |||
| 2016-05-20 | 2016-06-07 | 2016-05-24 | 2016-04-28 | 0.8 | Increase | |||
| 2016-02-19 | 2016-03-08 | 2016-02-23 | 2016-01-04 | 0.75 | No Change QoQ | |||
| 2015-11-20 | 2015-12-08 | 2015-11-24 | 2015-10-22 | 0.75 | No Change QoQ | |||
| 2015-08-21 | 2015-09-08 | 2015-08-25 | 2015-07-20 | 0.75 | No Change QoQ | |||
| 2015-05-21 | 2015-06-09 | 2015-05-26 | 2015-04-23 | 0.75 | Increase | |||
| 2015-02-20 | 2015-03-10 | 2015-02-24 | 2015-01-05 | 0.7 | No Change QoQ | |||
| 2014-11-21 | 2014-12-09 | 2014-11-25 | 2014-10-16 | 0.7 | No Change QoQ | |||
| 2019-11-25 | 2019-12-10 | 2019-11-26 | 2019-10-17 | 0.95 | No Change QoQ | |||
| 2019-11-25 | 2019-12-10 | 2019-11-26 | 2019-10-17 | 0.95 | Cash | |||
| 2019-11-25 | 2019-12-10 | 2019-11-26 | 2019-10-17 | 0.95 | Cash | |||
| 2020-02-24 | 2020-03-10 | 2020-02-25 | 2020-01-02 | 0.95 | Cash | |||
| 2020-05-22 | 2020-06-09 | 2020-05-26 | 2020-04-14 | 1.01 | Cash | |||
| 2020-08-24 | 2020-09-08 | 2020-08-25 | 2020-07-20 | 1.01 | Cash | |||
| 2020-11-23 | 2020-12-08 | 2020-11-24 | 2020-10-22 | 1.01 | Cash | |||
| 2021-02-22 | 2021-03-09 | 2021-02-23 | 2021-01-04 | 1.01 | Cash | |||
| 2021-05-24 | 2021-06-08 | 2021-05-25 | 2021-04-20 | 1.06 | Cash | |||
| 2021-08-23 | 2021-09-07 | 2021-08-24 | 2021-07-19 | 1.06 | Cash | |||
| 2021-11-22 | 2021-12-07 | 2021-11-23 | 2021-10-21 | 1.06 | Cash | |||
| 2022-02-18 | 2022-03-08 | 2022-02-22 | 2022-01-04 | 1.06 | Cash | |||
| 2022-05-23 | 2022-06-07 | 2022-05-24 | 2022-04-19 | 1.13 | Cash | |||
| 2022-08-22 | 2022-09-06 | 2022-08-23 | 2022-07-18 | 1.13 | Cash | |||
| 2022-11-21 | 2022-12-06 | 2022-11-22 | 2022-10-19 | 1.13 | Cash | |||
| 2023-02-17 | 2023-03-07 | 2023-02-21 | 2023-01-03 | 1.13 | Cash | |||
| 2023-05-22 | 2023-06-06 | 2023-05-23 | 2023-04-18 | 1.19 | Cash | |||
| 2023-08-25 | 2023-09-07 | 2023-08-28 | 2023-07-20 | 1.19 | Cash | |||
| 2023-11-20 | 2023-12-05 | 2023-11-21 | 2023-10-19 | 1.19 | Cash | |||
| 2024-02-16 | 2024-03-05 | 2024-02-20 | 2024-01-02 | 1.19 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|